Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?
KeywordsEnterovirus Immunohistochemistry Type 1 diabetes VP-1
Viral peptide 1
Human pancreatic islets were obtained from the Nordic Network for Clinical Islet Transplantation, supported by the Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden) and the JDRF.
This study was supported by grants from the Swedish Medical Research Council (65X-12219-15-6), the Knut and Alice Wallenberg Research Foundation, EU-FP7-Health 2010 PEVNET 261441 and the Novo Nordisk Foundation; OK’s position is in part supported by the National Institutes of Health (2U01AI065192-06).
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
All authors were responsible for the conception and design of the manuscript, drafting the article and revising it critically for important intellectual content. All authors approved the version to be published.
- 3.Dako (2003) Specification sheet for clone 5-D8/1, code no. M 7064. Available from www.dako.com/uk/download.pdf?objectid=104286003, accessed 29 November 2013
- 8.Kobayashi T, Nishida Y, Tanaka S, Aida K (2011) Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab Res Rev 27:965–970PubMedCrossRefGoogle Scholar
- 14.Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2011) Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 54:2417–2420PubMedCrossRefGoogle Scholar